Sartorius Aktiengesellschaft (ETR:SRT3)

Market Cap	12.37B
Revenue (ttm)	3.47B
Net Income (ttm)	104.10M
Shares Out	69.04M
EPS (ttm)	n/a
PE Ratio	118.84
Forward PE	67.62
Dividend	0.74 (0.38%)
Ex-Dividend Date	Mar 28, 2025

Volume	76,618
Average Volume	117,227
Open	191.90
Previous Close	192.75
Day's Range	191.65 - 197.40
52-Week Range	166.05 - 292.00
Beta	1.24
RSI	51.01
Earnings Date	Oct 16, 2025

About ETR:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 13,528
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SRT3

Financial Performance

In 2024, ETR:SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.